News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology



7/31/2014 11:30:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AUSTIN, Texas--(BUSINESS WIRE)--Mystic Pharmaceuticals, Inc., a privately held, integrated specialty pharmaceutical company, announced today it has received a Notice of Allowance from the United States Patent Office for its “Medical Devices For Dispensing Powders” (application 13/433,586). Mystic’s latest innovation enables patient self administration of drugs and biologics formulated as powders for systemic nasal, nose-to-brain, ophthalmic, sublingual and buccal routes of administration.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES